Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Spectracef (Cefditoren Pivoxil) Tablets, 200 mg, TAP Pharmaceutical Products NDA 21-222/S1 8/21/02 8/26/02 8/22/02 | Spectracef (Cefditoren Pivoxil) Tablets, 200 mg TAP Pharmaceutical Products NDA 21-222 8/29/01 11/5/01 11/5/01 12/7/01 | Spectracef Indications: Treatment of acute exacerbation of chronic bronchitis, pharyngitis/tonsillitis, and uncomplicated skin and skin structure infections. Spectracef (Cefditoren Pivoxil) Tablets, Purdue Pharmaceutical | Spectracef (cefditoren pivoxil) tablets, Purdue Pharma, Labeling Revision | SPECTRACEF (cefditoren pivoxil) Tablets, Cornerstone BioPharma, Formulation Revision | Spectracef, cefditoren pivoxil, Tablet; Oral, Vansen Pharma, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com